K. Adach, “Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy”, J EBM, vol. 3, no. 1(6), pp. 16-29, Apr. 2010.